Ram Doolman

3.0k total citations · 1 hit paper
54 papers, 1.8k citations indexed

About

Ram Doolman is a scholar working on Infectious Diseases, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ram Doolman has authored 54 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 8 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ram Doolman's work include SARS-CoV-2 and COVID-19 Research (19 papers), COVID-19 Clinical Research Studies (15 papers) and Vaccine Coverage and Hesitancy (7 papers). Ram Doolman is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (19 papers), COVID-19 Clinical Research Studies (15 papers) and Vaccine Coverage and Hesitancy (7 papers). Ram Doolman collaborates with scholars based in Israel, United States and United Kingdom. Ram Doolman's co-authors include Joseph Roitelman, Rachel Avner, Yaniv Lustig, Keren Asraf, Gili Regev‐Yochay, Yitshak Kreiss, Sharon Amit, Vincent Chau, Carmit Cohen and Emmanuel J. H. J. Wiertz and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Nature Immunology.

In The Last Decade

Ram Doolman

53 papers receiving 1.8k citations

Hit Papers

BNT162b2 COVID-19 vaccine and correlates of humoral immun... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ram Doolman Israel 21 746 408 288 253 240 54 1.8k
Katja Kotsch Germany 31 293 0.4× 598 1.5× 38 0.1× 675 2.7× 379 1.6× 89 3.3k
Alfred H.J. Kim United States 20 559 0.7× 224 0.5× 22 0.1× 97 0.4× 155 0.6× 58 1.6k
Norbert Vaessen Netherlands 19 400 0.5× 410 1.0× 44 0.2× 137 0.5× 330 1.4× 30 1.7k
Roberta Rossi Italy 20 906 1.2× 398 1.0× 66 0.2× 304 1.2× 267 1.1× 75 2.3k
Vaishali R. Moulton United States 23 427 0.6× 592 1.5× 23 0.1× 61 0.2× 130 0.5× 37 2.5k
Silvia Della Bella Italy 30 134 0.2× 424 1.0× 32 0.1× 156 0.6× 454 1.9× 71 2.5k
Juanjuan Zhao China 17 1.3k 1.7× 621 1.5× 30 0.1× 148 0.6× 531 2.2× 32 2.7k
Peter Hsu Australia 17 145 0.2× 232 0.6× 24 0.1× 262 1.0× 244 1.0× 44 1.5k
Alexandre Bélot France 28 766 1.0× 928 2.3× 14 0.0× 500 2.0× 375 1.6× 163 3.2k
Jette Junge Denmark 31 94 0.1× 344 0.8× 42 0.1× 795 3.1× 1.4k 5.7× 76 2.3k

Countries citing papers authored by Ram Doolman

Since Specialization
Citations

This map shows the geographic impact of Ram Doolman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ram Doolman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ram Doolman more than expected).

Fields of papers citing papers by Ram Doolman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ram Doolman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ram Doolman. The network helps show where Ram Doolman may publish in the future.

Co-authorship network of co-authors of Ram Doolman

This figure shows the co-authorship network connecting the top 25 collaborators of Ram Doolman. A scholar is included among the top collaborators of Ram Doolman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ram Doolman. Ram Doolman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lustig, Yaniv, Victoria Indenbaum, Ili Margalit, et al.. (2024). SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022 and 2023. Emerging infectious diseases. 30(5). 1050–1052. 2 indexed citations
2.
Lustig, Yaniv, Noam Barda, Victoria Indenbaum, et al.. (2024). Humoral response superiority of the monovalent XBB.1.5 over the bivalent BA.1 and BA.5 mRNA COVID-19 vaccines. Vaccine. 42(22). 126010–126010. 2 indexed citations
3.
Davidov, Yana, Victoria Indenbaum, Michal Mandelboim, et al.. (2023). Reduced Neutralization Efficacy against Omicron Variant after Third Boost of BNT162b2 Vaccine among Liver Transplant Recipients. Viruses. 15(1). 253–253. 1 indexed citations
4.
Gilboa, Mayan, Tal Gonen, Noam Barda, et al.. (2023). Factors Associated With Protection From SARS-CoV-2 Omicron Variant Infection and Disease Among Vaccinated Health Care Workers in Israel. JAMA Network Open. 6(5). e2314757–e2314757. 20 indexed citations
6.
Toussia‐Cohen, Shlomi, Yoav Yinon, Keren Asraf, et al.. (2022). Early Adverse Events and Immune Response Following Second and Third COVID-19 Vaccination in Pregnancy. Journal of Clinical Medicine. 11(16). 4720–4720. 7 indexed citations
7.
Toussia‐Cohen, Shlomi, et al.. (2022). Maternal and Neonatal Immune Responses Following COVID-19 Infection and Vaccinations in Pregnancy. Vaccines. 10(12). 2019–2019. 4 indexed citations
8.
Barda, Noam, Mayan Gilboa, Keren Asraf, et al.. (2022). The Association Between Prebooster Vaccination Antibody Levels and the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Clinical Infectious Diseases. 76(7). 1315–1317. 12 indexed citations
9.
Barda, Noam, Mayan Gilboa, Victoria Indenbaum, et al.. (2022). Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up. Nature Communications. 13(1). 7711–7711. 16 indexed citations
10.
Schwartz, A., Shlomi Toussia‐Cohen, Leah Leibovitch, et al.. (2021). Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies among parturient women treated with BNT162b2 messenger RNA vaccine during pregnancy. American Journal of Obstetrics & Gynecology MFM. 4(1). 100492–100492. 69 indexed citations
11.
Schwartz, A., Shlomi Toussia‐Cohen, Tzipora Strauss, et al.. (2021). Presence of SARS-CoV-2 antibodies in lactating women and their infants following BNT162b2 messenger RNA vaccine. American Journal of Obstetrics and Gynecology. 225(5). 577–579. 15 indexed citations
12.
Douvdevani, Amos, et al.. (2020). Circulating cell-free DNA (cfDNA) levels in BRCA1 and BRCA2 mutation carriers: A preliminary study. Cancer Biomarkers. 28(3). 269–273. 6 indexed citations
14.
Matetzky, Shlomi, Dov Freimark, Ilan Goldenberg, et al.. (2003). Association of Elevated Homocysteine Levels With a Higher Risk of Recurrent Coronary Events and Mortality in Patients With Acute Myocardial Infarction. Archives of Internal Medicine. 163(16). 1933–1933. 51 indexed citations
15.
Berner, Yitshal, Ben‐Ami Sela, John M. Gomori, et al.. (2003). Hyperhomocysteinemia and Vitamin Score: Correlations with Silent Brain Ischemic Lesions and Brain Atrophy. Dementia and Geriatric Cognitive Disorders. 16(1). 39–45. 17 indexed citations
16.
Harats, Dror, Ram Doolman, S Gavendo, et al.. (2001). Homocysteine elevation with fibrates: is it a class effect?. PubMed. 3(4). 243–6. 12 indexed citations
17.
Ravid, Tommer, Ram Doolman, Rachel Avner, Dror Harats, & Joseph Roitelman. (2000). The Ubiquitin-Proteasome Pathway Mediates the Regulated Degradation of Mammalian 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase. Journal of Biological Chemistry. 275(46). 35840–35847. 131 indexed citations
18.
Bank, Ilan, et al.. (1999). Detection of soluble α1 integrin in human serum. Journal of Laboratory and Clinical Medicine. 134(6). 599–604. 7 indexed citations
19.
Livneh, Avi, et al.. (1996). Recurrent aphthous stomatitis and thiamine deficiency. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 82(6). 634–636. 27 indexed citations
20.
Solomon, Beka, et al.. (1992). Microalbuminuria Immunoassay Based on Antibodies Covalently Conjugated to Eupergit C-Coated Beads. Diabetes Care. 15(11). 1451–1454. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026